Showing results (521-530 of 596) with videos related to
Sort By:
Pageof 60
Molecular and Cellular Biology|February 13, 2002
Genetic ablation of the CDP/Cux protein C terminus results in hair cycle defects and reduced male fertilityMai X Luong, Caroline M van der Meijden, DongXia Xing, et al.British Journal of Anaesthesia|March 13, 2019
Depth of sedation as an interventional target to reduce postoperative delirium: mortality and functional outcomes of the Strategy to Reduce the Incidence of Postoperative Delirium in Elderly Patients randomised clinical trialFrederick Sieber, Karin J Neufeld, Allan Gottschalk, et al.Pediatric Blood & Cancer|June 11, 2010
Education and employment status of children and adults with thalassemia in North AmericaZahra Pakbaz, Marsha Treadwell, Hae-Young Kim, et al.Journal of the American Geriatrics Society|January 19, 2024
Delirium detection tools show varying completion rates and positive score rates when used at scale in routine practice in general hospital settings: A systematic reviewRose S Penfold, Charlotte Squires, Alisa Angus, et al.Plos One|September 26, 2018
Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementiaEsther S Oh, Kaj Blennow, George E Bigelow, et al.Proceedings of the National Academy of Sciences of the United States of America|October 15, 1996
CDP/cut is the DNA-binding subunit of histone gene transcription factor HiNF-D: a mechanism for gene regulation at the G1/S phase cell cycle transition point independent of transcription factor E2FA J van Wijnen, M F van Gurp, M C de Ridder, et al.Human Brain Mapping|July 14, 2018
Intrinsic connectivity network dynamics in PTSD during amygdala downregulation using real-time fMRI neurofeedback: A preliminary analysisAndrew A Nicholson, Daniela Rabellino, Maria Densmore, et al.Blood|April 25, 2021
The cost-effectiveness of gene therapy for severe hemophilia B: a microsimulation study from the United States perspectiveNancy S Bolous, Yichen Chen, Huiqi Wang, et al.Blood|January 19, 2012
A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overloadEllis J Neufeld, Renzo Galanello, Vip Viprakasit, et al.The British Journal of Psychiatry : the Journal of Mental Science|October 2, 2007
Longitudinal grey-matter and glutamatergic losses in first-episode schizophreniaJean Théberge, Kate E Williamson, Naoko Aoyama, et al.Pageof 60